Rapid development of broadly influenza neutralizing antibodies through redundant mutations
The main pathway of somatic mutations leading to the generation of high affinity broadly neutralizing antibodies against the influenza haemagglutinin stem is defined. Anti-influenza antibody creation By reconstructing the genealogy trees of several influenza-specific human B cell clones, Antonio Lan...
Saved in:
Published in | Nature (London) Vol. 516; no. 7531; pp. 418 - 422 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
18.12.2014
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
ISSN | 0028-0836 1476-4687 1476-4687 |
DOI | 10.1038/nature13764 |
Cover
Loading…
Abstract | The main pathway of somatic mutations leading to the generation of high affinity broadly neutralizing antibodies against the influenza haemagglutinin stem is defined.
Anti-influenza antibody creation
By reconstructing the genealogy trees of several influenza-specific human B cell clones, Antonio Lanzavecchia and colleagues have identified a main pathway leading to high affinity broadly neutralizing antibodies against the stem regions of viral haemagglutinin molecules. In most instances a single point mutation confers high affinity binding and neutralization activity, with subsequent mutations conferring increased breadth of the response.
The neutralizing antibody response to influenza virus is dominated by antibodies that bind to the globular head of haemagglutinin, which undergoes a continuous antigenic drift, necessitating the re-formulation of influenza vaccines on an annual basis. Recently, several laboratories have described a new class of rare influenza-neutralizing antibodies that target a conserved site in the haemagglutinin stem
1
,
2
,
3
,
4
,
5
,
6
. Most of these antibodies use the heavy-chain variable region
VH1-69
gene, and structural data demonstrate that they bind to the haemagglutinin stem through conserved heavy-chain complementarity determining region (HCDR) residues. However, the VH1-69 antibodies are highly mutated and are produced by some but not all individuals
6
,
7
, suggesting that several somatic mutations may be required for their development
8
,
9
. To address this, here we characterize 197 anti-stem antibodies from a single donor, reconstruct the developmental pathways of several VH1-69 clones and identify two key elements that are required for the initial development of most VH1-69 antibodies: a polymorphic germline-encoded phenylalanine at position 54 and a conserved tyrosine at position 98 in HCDR3. Strikingly, in most cases a single proline to alanine mutation at position 52a in HCDR2 is sufficient to confer high affinity binding to the selecting H1 antigen, consistent with rapid affinity maturation. Surprisingly, additional favourable mutations continue to accumulate, increasing the breadth of reactivity and making both the initial mutations and phenylalanine at position 54 functionally redundant. These results define
VH1-69
allele polymorphism, rearrangement of the VDJ gene segments and single somatic mutations as the three requirements for generating broadly neutralizing VH1-69 antibodies and reveal an unexpected redundancy in the affinity maturation process. |
---|---|
AbstractList | The neutralizing antibody response to influenza virus is dominated by antibodies that bind to the globular head of haemagglutinin, which undergoes a continuous antigenic drift, necessitating the re-formulation of influenza vaccines on an annual basis. Recently, several laboratories have described a new class of rare influenza-neutralizing antibodies that target a conserved site in the haemagglutinin stem. Most of these antibodies use the heavy-chain variable region VH1-69 gene, and structural data demonstrate that they bind to the haemagglutinin stem through conserved heavy-chain complementarity determining region (HCDR) residues. However, the VH1-69 antibodies are highly mutated and are produced by some but not all individuals, suggesting that several somatic mutations may be required for their development. To address this, here we characterize 197 anti-stem antibodies from a single donor, reconstruct the developmental pathways of several VH1-69 clones and identify two key elements that are required for the initial development of most VH1-69 antibodies: a polymorphic germline-encoded phenylalanine at position 54 and a conserved tyrosine at position 98 in HCDR3. Strikingly, in most cases a single proline to alanine mutation at position 52a in HCDR2 is sufficient to confer high affinity binding to the selecting H1 antigen, consistent with rapid affinity maturation. Surprisingly, additional favourable mutations continue to accumulate, increasing the breadth of reactivity and making both the initial mutations and phenylalanine at position 54 functionally redundant. These results define VH1-69 allele polymorphism, rearrangement of the VDJ gene segments and single somatic mutations as the three requirements for generating broadly neutralizing VH1-69 antibodies and reveal an unexpected redundancy in the affinity maturation process.The neutralizing antibody response to influenza virus is dominated by antibodies that bind to the globular head of haemagglutinin, which undergoes a continuous antigenic drift, necessitating the re-formulation of influenza vaccines on an annual basis. Recently, several laboratories have described a new class of rare influenza-neutralizing antibodies that target a conserved site in the haemagglutinin stem. Most of these antibodies use the heavy-chain variable region VH1-69 gene, and structural data demonstrate that they bind to the haemagglutinin stem through conserved heavy-chain complementarity determining region (HCDR) residues. However, the VH1-69 antibodies are highly mutated and are produced by some but not all individuals, suggesting that several somatic mutations may be required for their development. To address this, here we characterize 197 anti-stem antibodies from a single donor, reconstruct the developmental pathways of several VH1-69 clones and identify two key elements that are required for the initial development of most VH1-69 antibodies: a polymorphic germline-encoded phenylalanine at position 54 and a conserved tyrosine at position 98 in HCDR3. Strikingly, in most cases a single proline to alanine mutation at position 52a in HCDR2 is sufficient to confer high affinity binding to the selecting H1 antigen, consistent with rapid affinity maturation. Surprisingly, additional favourable mutations continue to accumulate, increasing the breadth of reactivity and making both the initial mutations and phenylalanine at position 54 functionally redundant. These results define VH1-69 allele polymorphism, rearrangement of the VDJ gene segments and single somatic mutations as the three requirements for generating broadly neutralizing VH1-69 antibodies and reveal an unexpected redundancy in the affinity maturation process. The main pathway of somatic mutations leading to the generation of high affinity broadly neutralizing antibodies against the influenza haemagglutinin stem is defined. Anti-influenza antibody creation By reconstructing the genealogy trees of several influenza-specific human B cell clones, Antonio Lanzavecchia and colleagues have identified a main pathway leading to high affinity broadly neutralizing antibodies against the stem regions of viral haemagglutinin molecules. In most instances a single point mutation confers high affinity binding and neutralization activity, with subsequent mutations conferring increased breadth of the response. The neutralizing antibody response to influenza virus is dominated by antibodies that bind to the globular head of haemagglutinin, which undergoes a continuous antigenic drift, necessitating the re-formulation of influenza vaccines on an annual basis. Recently, several laboratories have described a new class of rare influenza-neutralizing antibodies that target a conserved site in the haemagglutinin stem 1 , 2 , 3 , 4 , 5 , 6 . Most of these antibodies use the heavy-chain variable region VH1-69 gene, and structural data demonstrate that they bind to the haemagglutinin stem through conserved heavy-chain complementarity determining region (HCDR) residues. However, the VH1-69 antibodies are highly mutated and are produced by some but not all individuals 6 , 7 , suggesting that several somatic mutations may be required for their development 8 , 9 . To address this, here we characterize 197 anti-stem antibodies from a single donor, reconstruct the developmental pathways of several VH1-69 clones and identify two key elements that are required for the initial development of most VH1-69 antibodies: a polymorphic germline-encoded phenylalanine at position 54 and a conserved tyrosine at position 98 in HCDR3. Strikingly, in most cases a single proline to alanine mutation at position 52a in HCDR2 is sufficient to confer high affinity binding to the selecting H1 antigen, consistent with rapid affinity maturation. Surprisingly, additional favourable mutations continue to accumulate, increasing the breadth of reactivity and making both the initial mutations and phenylalanine at position 54 functionally redundant. These results define VH1-69 allele polymorphism, rearrangement of the VDJ gene segments and single somatic mutations as the three requirements for generating broadly neutralizing VH1-69 antibodies and reveal an unexpected redundancy in the affinity maturation process. The neutralizing antibody response to influenza virus is dominated by antibodies that bind to the globular head of haemagglutinin, which undergoes a continuous antigenic drift, necessitating the re-formulation of influenza vaccines on an annual basis. Recently, several laboratories have described a new class of rare influenza-neutralizing antibodies that target a conserved site in the haemagglutinin stem. Most of these antibodies use the heavy-chain variable region VH1-69 gene, and structural data demonstrate that they bind to the haemagglutinin stem through conserved heavy-chain complementarity determining region (HCDR) residues. However, the VH1-69 antibodies are highly mutated and are produced by some but not all individuals, suggesting that several somatic mutations may be required for their development. To address this, here we characterize 197 anti-stem antibodies from a single donor, reconstruct the developmental pathways of several VH1-69 clones and identify two key elements that are required for the initial development of most VH1-69 antibodies: a polymorphic germline-encoded phenylalanine at position 54 and a conserved tyrosine at position 98 in HCDR3. Strikingly, in most cases a single proline to alanine mutation at position 52a in HCDR2 is sufficient to confer high affinity binding to the selecting H1 antigen, consistent with rapid affinity maturation. Surprisingly, additional favourable mutations continue to accumulate, increasing the breadth of reactivity and making both the initial mutations and phenylalanine at position 54 functionally redundant. These results define VH1-69 allele polymorphism, rearrangement of the VDJ gene segments and single somatic mutations as the three requirements for generating broadly neutralizing VH1-69 antibodies and reveal an unexpected redundancy in the affinity maturation process. |
Audience | Academic |
Author | Lanzavecchia, Antonio Pappas, Leontios Pellicciotta, Gabriele Kallewaard, Nicole L. Giacchetto-Sasselli, Isabella Silacci, Chiara Zhu, Qing Piccoli, Luca Sallusto, Federica Vicenzi, Elisa Corti, Davide Turrini, Filippo Fernandez-Rodriguez, Blanca Foglierini, Mathilde Agatic, Gloria |
Author_xml | – sequence: 1 givenname: Leontios surname: Pappas fullname: Pappas, Leontios organization: Insitute for Research in Biomedicine, Università della Svizzera Italiana, Via Vincenzo Vela 6, 6500 Bellinzona, Switzerland – sequence: 2 givenname: Mathilde surname: Foglierini fullname: Foglierini, Mathilde organization: Insitute for Research in Biomedicine, Università della Svizzera Italiana, Via Vincenzo Vela 6, 6500 Bellinzona, Switzerland – sequence: 3 givenname: Luca surname: Piccoli fullname: Piccoli, Luca organization: Insitute for Research in Biomedicine, Università della Svizzera Italiana, Via Vincenzo Vela 6, 6500 Bellinzona, Switzerland – sequence: 4 givenname: Nicole L. surname: Kallewaard fullname: Kallewaard, Nicole L. organization: Department of Infectious Diseases and Vaccines MedImmune LLC, One MedImmune Way – sequence: 5 givenname: Filippo surname: Turrini fullname: Turrini, Filippo organization: Viral Pathogens and Biosafety Unit, San Raffaele Scientific Institute, Via Olgettina 58, 20132 Milan, Italy – sequence: 6 givenname: Chiara surname: Silacci fullname: Silacci, Chiara organization: Insitute for Research in Biomedicine, Università della Svizzera Italiana, Via Vincenzo Vela 6, 6500 Bellinzona, Switzerland – sequence: 7 givenname: Blanca surname: Fernandez-Rodriguez fullname: Fernandez-Rodriguez, Blanca organization: Insitute for Research in Biomedicine, Università della Svizzera Italiana, Via Vincenzo Vela 6, 6500 Bellinzona, Switzerland – sequence: 8 givenname: Gloria surname: Agatic fullname: Agatic, Gloria organization: Humabs BioMed SA, Via Mirasole 1, 6500 Bellinzona, Switzerland – sequence: 9 givenname: Isabella surname: Giacchetto-Sasselli fullname: Giacchetto-Sasselli, Isabella organization: Insitute for Research in Biomedicine, Università della Svizzera Italiana, Via Vincenzo Vela 6, 6500 Bellinzona, Switzerland – sequence: 10 givenname: Gabriele surname: Pellicciotta fullname: Pellicciotta, Gabriele organization: Unit of Preventive Medicine, San Raffaele Scientific Institute, Via Olgettina 58, 20132 Milan, Italy – sequence: 11 givenname: Federica surname: Sallusto fullname: Sallusto, Federica organization: Insitute for Research in Biomedicine, Università della Svizzera Italiana, Via Vincenzo Vela 6, 6500 Bellinzona, Switzerland – sequence: 12 givenname: Qing surname: Zhu fullname: Zhu, Qing organization: Department of Infectious Diseases and Vaccines MedImmune LLC, One MedImmune Way – sequence: 13 givenname: Elisa surname: Vicenzi fullname: Vicenzi, Elisa organization: Viral Pathogens and Biosafety Unit, San Raffaele Scientific Institute, Via Olgettina 58, 20132 Milan, Italy – sequence: 14 givenname: Davide surname: Corti fullname: Corti, Davide organization: Insitute for Research in Biomedicine, Università della Svizzera Italiana, Via Vincenzo Vela 6, 6500 Bellinzona, Switzerland, Humabs BioMed SA, Via Mirasole 1, 6500 Bellinzona, Switzerland – sequence: 15 givenname: Antonio surname: Lanzavecchia fullname: Lanzavecchia, Antonio email: lanzavecchia@irb.usi.ch organization: Insitute for Research in Biomedicine, Università della Svizzera Italiana, Via Vincenzo Vela 6, 6500 Bellinzona, Switzerland, Insitute for Microbiology, ETH Zurich, Wolfgang-Pauli-Strasse 10, 8093 Zurich, Switzerland |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25296253$$D View this record in MEDLINE/PubMed |
BookMark | eNp10ktv1DAQAGALFdFt4cQdRXABQYqdOI5zrCoelSohFbhwiRx7nLpK7K0fiPbX49UW2K2CfLBkfzPyeOYIHVhnAaHnBJ8QXPP3VsTkgdQto4_QitCWlZTx9gCtMK54iXnNDtFRCNcY44a09Ak6rJqqY1VTr9CPS7E2qlDwEya3nsHGwuli8E6o6bYwVk8J7J0oLKToxWTujB0LYaMZnDIQinjlXRqvCg8qWZUvijlFEY2z4Sl6rMUU4Nn9foy-f_zw7exzefHl0_nZ6UUpG85iKQgB3ahBk440FWVKEwpqqAglmMtaaslZJwfBeKOlrJjCWLC2oTVALkiL-hi93uZde3eTIMR-NkHCNAkLLoWesLqjHa9wnemrB_TaJW_z67KimLUt68g_NYoJ-vwHLpcuN0n7U8pqThijG1UuqBEs5H_KHdImH-_5lwters1Nv4tOFlBeCmYjF7O-2QvIJsKvOIoUQn_-9XLfvrivPg0zqH7tzSz8bf9nGjJ4uwXSuxA86L-E4H4za_3OrGVNHmhptq3PbzbTf2LebWNCzmxH8DsNWOC_ATQ65J4 |
CODEN | NATUAS |
CitedBy_id | crossref_primary_10_1093_intimm_dxz049 crossref_primary_10_15252_embj_201899243 crossref_primary_10_1126_scitranslmed_ads8214 crossref_primary_10_3389_fimmu_2024_1471396 crossref_primary_10_1186_s12879_018_3517_7 crossref_primary_10_1371_journal_ppat_1011554 crossref_primary_10_1038_s41586_020_2456_9 crossref_primary_10_1128_mBio_01144_21 crossref_primary_10_3389_fimmu_2018_03004 crossref_primary_10_1038_s41564_021_00972_2 crossref_primary_10_1111_imm_13012 crossref_primary_10_1016_j_it_2017_04_003 crossref_primary_10_1016_j_it_2015_04_005 crossref_primary_10_1016_j_coviro_2022_101207 crossref_primary_10_1016_j_coi_2018_04_009 crossref_primary_10_1007_s00251_024_01363_7 crossref_primary_10_3389_fimmu_2019_02365 crossref_primary_10_1101_cshperspect_a029413 crossref_primary_10_1016_j_chom_2020_05_010 crossref_primary_10_3390_vaccines8030424 crossref_primary_10_1126_science_aad5224 crossref_primary_10_3389_fimmu_2018_02149 crossref_primary_10_1016_j_celrep_2023_112370 crossref_primary_10_1016_j_jim_2020_112752 crossref_primary_10_1016_j_coviro_2019_02_004 crossref_primary_10_1172_JCI99597 crossref_primary_10_1016_j_celrep_2017_11_056 crossref_primary_10_1371_journal_pbio_1002321 crossref_primary_10_1146_annurev_animal_021419_083813 crossref_primary_10_1016_j_immuni_2019_09_016 crossref_primary_10_1016_j_coviro_2016_03_002 crossref_primary_10_3389_fimmu_2021_730471 crossref_primary_10_3390_vaccines11101577 crossref_primary_10_2217_fvl_2016_0045 crossref_primary_10_1007_s00401_017_1705_y crossref_primary_10_1016_j_immuni_2023_06_019 crossref_primary_10_3390_microorganisms8111745 crossref_primary_10_1016_j_celrep_2017_08_084 crossref_primary_10_1126_sciimmunol_aan2676 crossref_primary_10_1016_j_celrep_2019_03_020 crossref_primary_10_1126_sciimmunol_aap8029 crossref_primary_10_1016_j_biotechadv_2023_108143 crossref_primary_10_3389_fimmu_2022_951385 crossref_primary_10_1038_ncomms13577 crossref_primary_10_3389_fimmu_2021_662909 crossref_primary_10_1093_abt_tbab008 crossref_primary_10_1038_nm_3963 crossref_primary_10_1093_intimm_dxaa028 crossref_primary_10_3389_fimmu_2017_01407 crossref_primary_10_1016_j_cell_2015_06_057 crossref_primary_10_3390_vaccines9020125 crossref_primary_10_1016_j_jconrel_2019_08_039 crossref_primary_10_1038_s41467_017_00736_9 crossref_primary_10_1371_journal_pone_0225063 crossref_primary_10_1016_j_micinf_2020_06_003 crossref_primary_10_1084_jem_20240668 crossref_primary_10_1172_JCI178880 crossref_primary_10_1111_imr_12395 crossref_primary_10_1371_journal_ppat_1011514 crossref_primary_10_1038_s41591_021_01636_8 crossref_primary_10_2139_ssrn_3272234 crossref_primary_10_1084_jem_20200206 crossref_primary_10_1016_j_chom_2019_01_010 crossref_primary_10_1172_jci_insight_129035 crossref_primary_10_3389_fimmu_2021_708882 crossref_primary_10_1073_pnas_1500788112 crossref_primary_10_1038_s41467_020_14579_4 crossref_primary_10_1016_j_cell_2017_04_024 crossref_primary_10_7554_eLife_83628 crossref_primary_10_1016_j_tim_2016_09_003 crossref_primary_10_1107_S2053230X14027599 crossref_primary_10_1016_j_cell_2015_10_004 crossref_primary_10_1038_s41467_025_56496_4 crossref_primary_10_1038_s41467_022_29950_w crossref_primary_10_1093_nar_gkac995 crossref_primary_10_1016_j_immuni_2021_02_013 crossref_primary_10_3389_fimmu_2018_00600 crossref_primary_10_1016_j_molimm_2018_02_013 crossref_primary_10_1038_s41467_023_39690_0 crossref_primary_10_1016_j_celrep_2021_109604 crossref_primary_10_1016_j_it_2022_11_001 crossref_primary_10_1016_j_immuni_2022_07_006 crossref_primary_10_3389_fimmu_2019_00829 crossref_primary_10_1016_j_cels_2020_09_005 crossref_primary_10_1089_aid_2022_0104 crossref_primary_10_15252_emmm_201808879 crossref_primary_10_1098_rstb_2014_0236 crossref_primary_10_1016_j_celrep_2019_12_063 crossref_primary_10_1016_j_immuni_2024_07_022 crossref_primary_10_1038_srep33843 crossref_primary_10_3390_cells10081864 crossref_primary_10_1146_annurev_immunol_041015_055325 crossref_primary_10_1128_JVI_01850_17 crossref_primary_10_1126_science_aap9608 crossref_primary_10_1016_j_chom_2017_07_013 crossref_primary_10_1021_acssuschemeng_2c01760 crossref_primary_10_1080_22221751_2022_2140611 crossref_primary_10_1016_j_immuni_2023_11_004 crossref_primary_10_1038_nature16450 crossref_primary_10_1002_anbr_202100122 crossref_primary_10_1016_j_immuni_2020_10_005 crossref_primary_10_1016_j_cell_2016_06_043 crossref_primary_10_1038_s41467_024_51770_3 crossref_primary_10_1073_pnas_1614940113 crossref_primary_10_1038_ncomms13376 crossref_primary_10_1371_journal_ppat_1011603 crossref_primary_10_1016_j_coviro_2015_03_019 crossref_primary_10_1111_imr_12509 crossref_primary_10_1146_annurev_immunol_102819_023144 crossref_primary_10_1146_annurev_med_091014_090749 crossref_primary_10_1016_j_csbj_2019_03_009 crossref_primary_10_3389_fimmu_2015_00531 crossref_primary_10_1016_j_chom_2016_05_014 crossref_primary_10_1016_j_coi_2018_05_010 crossref_primary_10_1038_nri_2016_67 crossref_primary_10_1038_s41541_017_0019_3 crossref_primary_10_1016_j_coi_2016_12_004 crossref_primary_10_1016_j_celrep_2024_114990 crossref_primary_10_3390_v12091053 crossref_primary_10_1016_j_chom_2018_10_009 crossref_primary_10_1016_j_immuni_2021_12_003 crossref_primary_10_1016_j_coi_2017_03_002 crossref_primary_10_1021_acssensors_9b00968 crossref_primary_10_1128_jvi_01223_24 crossref_primary_10_1038_s41435_021_00145_5 crossref_primary_10_1089_vim_2017_0025 crossref_primary_10_1111_all_13394 crossref_primary_10_1038_ncomms9223 crossref_primary_10_1038_ncomms8375 crossref_primary_10_1038_s41467_019_11821_6 crossref_primary_10_1016_j_coi_2016_06_001 crossref_primary_10_1016_j_immuni_2015_11_007 crossref_primary_10_1016_j_vaccine_2017_10_093 crossref_primary_10_1016_j_celrep_2023_113194 crossref_primary_10_1016_j_antiviral_2023_105591 crossref_primary_10_1016_j_immuni_2021_08_013 crossref_primary_10_1016_j_celrep_2022_110763 crossref_primary_10_1080_22221751_2021_1925594 crossref_primary_10_1016_j_vaccine_2017_08_053 crossref_primary_10_1016_j_chom_2018_09_010 crossref_primary_10_1016_j_celrep_2021_108950 crossref_primary_10_3390_vaccines8030382 crossref_primary_10_1038_s41564_023_01413_y crossref_primary_10_1016_j_coisb_2019_10_004 crossref_primary_10_1128_JVI_00093_16 crossref_primary_10_3389_fimmu_2023_1201136 crossref_primary_10_1126_scitranslmed_ade4976 crossref_primary_10_1093_infdis_jiy696 crossref_primary_10_3390_vaccines9111352 crossref_primary_10_1016_j_coviro_2017_03_002 crossref_primary_10_1084_jem_20231314 crossref_primary_10_3389_fimmu_2018_02451 crossref_primary_10_1038_s41541_021_00342_3 crossref_primary_10_1038_s41392_021_00858_z crossref_primary_10_4049_jimmunol_1701728 crossref_primary_10_3389_fimmu_2016_00619 crossref_primary_10_1002_art_40590 crossref_primary_10_1016_j_immuni_2016_10_027 crossref_primary_10_1016_j_coviro_2015_04_002 crossref_primary_10_3389_fimmu_2017_00143 crossref_primary_10_1016_j_antiviral_2019_104564 crossref_primary_10_1126_science_aaf8505 crossref_primary_10_1371_journal_pone_0183315 crossref_primary_10_1016_j_isci_2024_109716 crossref_primary_10_1128_CVI_00544_16 crossref_primary_10_1016_j_celrep_2020_108430 crossref_primary_10_1038_srep15053 crossref_primary_10_1038_nri_2017_78 crossref_primary_10_1093_protein_gzz013 crossref_primary_10_1016_j_chom_2017_08_011 crossref_primary_10_3390_vaccines10081227 crossref_primary_10_1080_22221751_2019_1701953 crossref_primary_10_1016_j_celrep_2020_108088 crossref_primary_10_3390_vaccines7020053 crossref_primary_10_1038_ncomms15371 crossref_primary_10_1038_s41590_023_01559_1 crossref_primary_10_1038_srep37229 crossref_primary_10_1038_s41467_021_24090_z crossref_primary_10_3389_fimmu_2020_01011 crossref_primary_10_1111_imr_12821 crossref_primary_10_1038_s41541_024_00811_5 crossref_primary_10_1038_srep35173 crossref_primary_10_1084_jem_20191792 crossref_primary_10_1002_eji_202451045 crossref_primary_10_1016_j_celrep_2019_11_084 crossref_primary_10_1016_j_it_2020_03_005 crossref_primary_10_1093_infdis_jiab064 crossref_primary_10_1371_journal_pcbi_1007731 crossref_primary_10_1038_ncomms12780 crossref_primary_10_1016_j_immuni_2016_04_016 crossref_primary_10_1186_s12936_020_03548_3 crossref_primary_10_1007_s13238_015_0160_6 crossref_primary_10_1038_s41418_019_0318_5 crossref_primary_10_1084_jem_20200513 crossref_primary_10_1016_j_jmb_2023_168344 crossref_primary_10_1016_j_smim_2015_03_008 crossref_primary_10_1038_nm_4513 crossref_primary_10_1111_imr_12808 crossref_primary_10_1016_j_immuni_2019_09_001 crossref_primary_10_1038_srep32340 crossref_primary_10_1128_JVI_00880_16 crossref_primary_10_1016_j_cell_2015_12_022 crossref_primary_10_1016_j_immuni_2018_08_025 crossref_primary_10_1016_j_immuni_2017_12_009 crossref_primary_10_1073_pnas_1901340116 crossref_primary_10_1016_j_coisb_2018_11_002 crossref_primary_10_7554_eLife_81743 crossref_primary_10_1016_j_celrep_2020_108065 crossref_primary_10_3390_v13071392 crossref_primary_10_1080_22221751_2023_2245931 crossref_primary_10_1172_JCI148763 crossref_primary_10_1038_s41541_017_0020_x crossref_primary_10_1084_jem_20142284 crossref_primary_10_1016_j_jaut_2024_103241 crossref_primary_10_1038_srep20842 crossref_primary_10_1111_jth_13956 crossref_primary_10_4049_jimmunol_1402835 crossref_primary_10_1016_j_celrep_2023_113410 crossref_primary_10_1038_s41467_021_21968_w crossref_primary_10_1038_s42003_017_0006_2 crossref_primary_10_1172_jci_insight_135449 crossref_primary_10_7554_eLife_71393 crossref_primary_10_1093_protein_gzaa028 crossref_primary_10_1016_j_cell_2016_05_073 crossref_primary_10_3390_v13060965 crossref_primary_10_3389_fimmu_2018_01315 crossref_primary_10_3390_vaccines8010013 crossref_primary_10_1038_nprot_2016_009 crossref_primary_10_1016_j_coi_2015_02_011 crossref_primary_10_1016_j_immuni_2016_09_001 crossref_primary_10_1016_j_molimm_2021_08_017 crossref_primary_10_1126_scitranslmed_aad0522 crossref_primary_10_1038_s41590_022_01230_1 crossref_primary_10_1038_srep12411 crossref_primary_10_1073_pnas_2412787122 crossref_primary_10_1126_sciadv_aav1882 crossref_primary_10_1093_brain_awz106 crossref_primary_10_1016_j_coi_2018_03_020 crossref_primary_10_1080_19420862_2016_1170263 crossref_primary_10_3389_fimmu_2017_01563 crossref_primary_10_1016_j_celrep_2018_07_093 |
Cites_doi | 10.1126/science.1171491 10.1016/S1074-7613(00)80580-4 10.1073/pnas.1218256109 10.1371/journal.ppat.1004103 10.1016/S0042-6822(02)00035-1 10.1093/intimm/dxt030 10.1073/pnas.92.5.1254 10.1016/j.jim.2007.09.017 10.1084/jem.20101352 10.1016/j.cell.2013.03.018 10.1093/rheumatology/41.4.401 10.1038/ni.1814 10.1038/nature12442 10.1111/j.1750-2659.2007.00016.x 10.1038/nature12053 10.1128/CVI.00735-12 10.1093/nar/gkt382 10.1073/pnas.81.10.3180 10.1038/nsmb.1566 10.1016/j.molimm.2008.05.022 10.4049/jimmunol.1000928 10.1371/journal.pone.0022365 10.1097/01.aids.0000432474.76873.5f 10.1038/nri3516 10.1038/354389a0 10.1073/pnas.1301810110 10.1126/science.1205669 10.1172/JCI41902 10.1038/nature11371 10.1371/journal.pone.0003942 10.1016/j.vaccine.2009.10.066 10.1093/nar/gkn316 10.1038/nm1080 10.1172/JCI116468 10.1126/science.1222908 10.1146/annurev-immunol-020711-075032 10.1172/JCI118644 10.1126/science.1201730 10.1093/nar/gkq313 |
ContentType | Journal Article |
Copyright | Springer Nature Limited 2014 COPYRIGHT 2014 Nature Publishing Group Copyright Nature Publishing Group Dec 18-Dec 25, 2014 |
Copyright_xml | – notice: Springer Nature Limited 2014 – notice: COPYRIGHT 2014 Nature Publishing Group – notice: Copyright Nature Publishing Group Dec 18-Dec 25, 2014 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QG 7QL 7QP 7QR 7RV 7SN 7SS 7ST 7T5 7TG 7TK 7TM 7TO 7U9 7X2 7X7 7XB 88A 88E 88G 88I 8AF 8AO 8C1 8FD 8FE 8FG 8FH 8FI 8FJ 8FK 8G5 ABJCF ABUWG AEUYN AFKRA ARAPS ATCPS AZQEC BBNVY BEC BENPR BGLVJ BHPHI BKSAR C1K CCPQU D1I DWQXO FR3 FYUFA GHDGH GNUQQ GUQSH H94 HCIFZ K9. KB. KB0 KL. L6V LK8 M0K M0S M1P M2M M2O M2P M7N M7P M7S MBDVC NAPCQ P5Z P62 P64 PATMY PCBAR PDBOC PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PSYQQ PTHSS PYCSY Q9U R05 RC3 S0X SOI 7X8 |
DOI | 10.1038/nature13764 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Nursing & Allied Health Database Ecology Abstracts Entomology Abstracts (Full archive) Environment Abstracts Immunology Abstracts Meteorological & Geoastrophysical Abstracts Neurosciences Abstracts Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts Agricultural Science Collection Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) Psychology Database (Alumni) Science Database (Alumni Edition) STEM Database ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni Edition) Materials Science & Engineering Collection (subscription) ProQuest Central (Alumni Edition) ProQuest One Sustainability (subscription) ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection Agricultural & Environmental Science Collection (subscription) ProQuest Central Essentials Biological Science Collection eLibrary ProQuest Central - New (Subscription) Technology Collection Natural Science Collection Earth, Atmospheric & Aquatic Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Materials Science Collection ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Materials Science Database Nursing & Allied Health Database (Alumni Edition) Meteorological & Geoastrophysical Abstracts - Academic ProQuest Engineering Collection ProQuest Biological Science Collection Agricultural Science Database Health & Medical Collection (Alumni Edition) Medical Database Psychology Database Research Library (subscription) Science Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Engineering Database (subscription) Research Library (Corporate) Nursing & Allied Health Premium ProQuest advanced technologies & aerospace journals ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts Environmental Science Database (subscripiton) Earth, Atmospheric & Aquatic Science Database Materials Science Collection ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology Engineering collection Environmental Science Collection ProQuest Central Basic University of Michigan Genetics Abstracts SIRS Editorial Environment Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Agricultural Science Database ProQuest One Psychology Research Library Prep ProQuest Central Student Oncogenes and Growth Factors Abstracts ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts elibrary ProQuest AP Science SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Meteorological & Geoastrophysical Abstracts Natural Science Collection Health & Medical Research Collection Biological Science Collection Chemoreception Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) Engineering Collection Advanced Technologies & Aerospace Collection Engineering Database Virology and AIDS Abstracts ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Earth, Atmospheric & Aquatic Science Database Agricultural Science Collection ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Environmental Science Collection Entomology Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Environmental Science Database ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts Meteorological & Geoastrophysical Abstracts - Academic ProQuest One Academic (New) University of Michigan Technology Collection Technology Research Database ProQuest One Academic Middle East (New) SIRS Editorial Materials Science Collection ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Biology Journals (Alumni Edition) ProQuest Central Earth, Atmospheric & Aquatic Science Collection ProQuest Health & Medical Research Collection Genetics Abstracts ProQuest Engineering Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Agricultural & Environmental Science Collection AIDS and Cancer Research Abstracts Materials Science Database ProQuest Research Library ProQuest Materials Science Collection ProQuest Public Health ProQuest Central Basic ProQuest Science Journals ProQuest Nursing & Allied Health Source ProQuest Psychology Journals (Alumni) ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library ProQuest Psychology Journals Animal Behavior Abstracts Materials Science & Engineering Collection Immunology Abstracts Environment Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Agricultural Science Database MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Sciences (General) Physics |
EISSN | 1476-4687 |
EndPage | 422 |
ExternalDocumentID | 3538303011 A463816641 25296253 10_1038_nature13764 |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIAID NIH HHS grantid: U19 AI-057266 |
GroupedDBID | --- --Z -DZ -ET -~X .55 .CO .XZ 00M 07C 0R~ 0WA 123 186 1OL 1VR 29M 2KS 2XV 39C 3V. 4.4 41X 53G 5RE 6TJ 70F 7RV 7X2 7X7 7XC 85S 88A 88E 88I 8AF 8AO 8C1 8CJ 8FE 8FG 8FH 8FI 8FJ 8G5 8R4 8R5 8WZ 97F 97L A6W A7Z A8Z AAEEF AAHBH AAHTB AAIKC AAKAB AAKAS AAMNW AASDW AAYEP AAYZH AAZLF ABAWZ ABDBF ABDQB ABFSI ABIVO ABJCF ABJNI ABLJU ABOCM ABPEJ ABPPZ ABUWG ABWJO ABZEH ACBEA ACBWK ACGFO ACGFS ACGOD ACIWK ACKOT ACMJI ACNCT ACPRK ACUHS ACWUS ADBBV ADFRT ADUKH ADYSU ADZCM AENEX AEUYN AFFNX AFKRA AFLOW AFRAH AFSHS AGAYW AGHSJ AGHTU AGNAY AGSOS AHMBA AHSBF AIDAL AIDUJ ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS AMTXH APEBS ARAPS ARMCB ARTTT ASPBG ATCPS ATWCN AVWKF AXYYD AZFZN AZQEC B0M BBNVY BCU BDKGC BEC BENPR BGLVJ BHPHI BIN BKEYQ BKKNO BKSAR BLC BPHCQ BVXVI CCPQU CJ0 CS3 D1I D1J D1K DO4 DU5 DWQXO E.- E.L EAD EAP EAS EAZ EBC EBD EBO EBS ECC EE. EJD EMB EMF EMH EMK EMOBN EPL EPS ESE ESN ESX EX3 EXGXG F5P FEDTE FQGFK FSGXE FYUFA GNUQQ GUQSH HCIFZ HMCUK HVGLF HZ~ I-F IAO ICQ IEA IEP IGS IH2 IHR INH INR IOF IPY ISR ITC K6- KB. KOO L6V L7B LK5 LK8 LSO M0K M0L M1P M2M M2O M2P M7P M7R M7S N9A NAPCQ NEJ NEPJS O9- OBC OES OHH OMK OVD P-O P2P P62 PATMY PCBAR PDBOC PKN PM3 PQQKQ PROAC PSQYO PSYQQ PTHSS PYCSY Q2X R05 RND RNS RNT RNTTT RXW S0X SC5 SHXYY SIXXV SJFOW SJN SNYQT SOJ SV3 TAE TAOOD TBHMF TDRGL TEORI TH9 TN5 TSG TUS TWZ U5U UIG UKHRP UKR UMD UQL VQA VVN WH7 WOW X7M XIH XKW XZL Y6R YAE YCJ YFH YIF YIN YNT YOC YQT YR2 YR5 YXB YZZ Z5M ZCA ZE2 ZKB ~02 ~7V ~88 ~8M ~KM AARCD AAYXX ABFSG ACMFV ACSTC ADGHP ADXHL AETEA AFANA ALPWD ATHPR CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM AEIIB PMFND 7QG 7QL 7QP 7QR 7SN 7SS 7ST 7T5 7TG 7TK 7TM 7TO 7U9 7XB 8FD 8FK C1K FR3 H94 K9. KL. M7N MBDVC P64 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS Q9U RC3 SOI 7X8 |
ID | FETCH-LOGICAL-c586t-a11ef5dbf1915246df14edb214108c3cfc869cba685fcc26d00a67543ee000fa3 |
IEDL.DBID | 8C1 |
ISSN | 0028-0836 1476-4687 |
IngestDate | Fri Jul 11 04:27:42 EDT 2025 Fri Jul 25 09:03:25 EDT 2025 Tue Jun 17 21:18:30 EDT 2025 Thu Jun 12 23:37:43 EDT 2025 Tue Jun 10 15:33:04 EDT 2025 Tue Jun 10 20:28:29 EDT 2025 Fri Jun 27 03:57:58 EDT 2025 Wed Feb 19 01:55:39 EST 2025 Tue Jul 01 03:21:24 EDT 2025 Thu Apr 24 23:10:58 EDT 2025 Fri Feb 21 02:37:48 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7531 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c586t-a11ef5dbf1915246df14edb214108c3cfc869cba685fcc26d00a67543ee000fa3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
PMID | 25296253 |
PQID | 1640677691 |
PQPubID | 40569 |
PageCount | 5 |
ParticipantIDs | proquest_miscellaneous_1639498203 proquest_journals_1640677691 gale_infotracmisc_A463816641 gale_infotracgeneralonefile_A463816641 gale_infotraccpiq_463816641 gale_infotracacademiconefile_A463816641 gale_incontextgauss_ISR_A463816641 pubmed_primary_25296253 crossref_primary_10_1038_nature13764 crossref_citationtrail_10_1038_nature13764 springer_journals_10_1038_nature13764 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2014-12-18 |
PublicationDateYYYYMMDD | 2014-12-18 |
PublicationDate_xml | – month: 12 year: 2014 text: 2014-12-18 day: 18 |
PublicationDecade | 2010 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationSubtitle | International weekly journal of science |
PublicationTitle | Nature (London) |
PublicationTitleAbbrev | Nature |
PublicationTitleAlternate | Nature |
PublicationYear | 2014 |
Publisher | Nature Publishing Group UK Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
References | Brochet, Lefranc, Giudicelli (CR37) 2008; 36 Sangster (CR15) 2013; 20 Arnaout (CR38) 2011; 6 Throsby (CR5) 2008; 3 Victora, Nussenzweig (CR23) 2012; 30 Lingwood (CR9) 2012; 489 Poulsen, Jensen, Haurum, Andersen (CR21) 2011; 187 Hassantoufighi (CR33) 2010; 28 Tiller (CR32) 2008; 329 Ye, Ma, Madden, Ostell (CR36) 2013; 41 Jacob, Kelsoe, Rajewsky, Weiss (CR10) 1991; 354 Foote, Eisen (CR20) 1995; 92 Sasso, Willems van Dijk, Bull, Milner (CR39) 1993; 91 Wrammert (CR6) 2011; 208 Kwong, Mascola, Nabel (CR22) 2013; 13 Jin (CR28) 2003; 306 Klein (CR17) 2013; 153 McKean (CR11) 1984; 81 Vencovský (CR14) 2002; 41 Avnir (CR16) 2014; 10 Batista, Neuberger (CR19) 1998; 8 Corti (CR7) 2010; 120 Traggiai (CR31) 2004; 10 Kaji (CR26) 2013; 25 Corti (CR4) 2011; 333 Goujon (CR34) 2010; 38 Dogan (CR24) 2009; 10 Dreyfus (CR3) 2012; 337 Wang (CR8) 2013; 110 Sasso, Johnson, Kipps (CR13) 1996; 97 Schmidt (CR18) 2013; 110 Sui (CR1) 2009; 16 Liao (CR12) 2013; 496 Abhinandan, Martin (CR35) 2008; 45 Corti (CR27) 2013; 501 Ekiert (CR2) 2009; 324 Pape, Taylor, Maul, Gearhart, Jenkins (CR25) 2011; 331 Temperton (CR29) 2007; 1 Ghezzi (CR30) 2013; 27 PD Kwong (BFnature13764_CR22) 2013; 13 E Traggiai (BFnature13764_CR31) 2004; 10 M Throsby (BFnature13764_CR5) 2008; 3 KA Pape (BFnature13764_CR25) 2011; 331 AG Schmidt (BFnature13764_CR18) 2013; 110 J Ye (BFnature13764_CR36) 2013; 41 D Corti (BFnature13764_CR27) 2013; 501 KR Abhinandan (BFnature13764_CR35) 2008; 45 T Kaji (BFnature13764_CR26) 2013; 25 F Wang (BFnature13764_CR8) 2013; 110 EH Sasso (BFnature13764_CR39) 1993; 91 EH Sasso (BFnature13764_CR13) 1996; 97 D McKean (BFnature13764_CR11) 1984; 81 S Ghezzi (BFnature13764_CR30) 2013; 27 NJ Temperton (BFnature13764_CR29) 2007; 1 X Brochet (BFnature13764_CR37) 2008; 36 R Arnaout (BFnature13764_CR38) 2011; 6 MY Sangster (BFnature13764_CR15) 2013; 20 DC Ekiert (BFnature13764_CR2) 2009; 324 C Dreyfus (BFnature13764_CR3) 2012; 337 H Jin (BFnature13764_CR28) 2003; 306 J Wrammert (BFnature13764_CR6) 2011; 208 D Corti (BFnature13764_CR4) 2011; 333 GD Victora (BFnature13764_CR23) 2012; 30 F Batista (BFnature13764_CR19) 1998; 8 Y Avnir (BFnature13764_CR16) 2014; 10 D Corti (BFnature13764_CR7) 2010; 120 F Klein (BFnature13764_CR17) 2013; 153 D Lingwood (BFnature13764_CR9) 2012; 489 A Hassantoufighi (BFnature13764_CR33) 2010; 28 M Goujon (BFnature13764_CR34) 2010; 38 J Vencovský (BFnature13764_CR14) 2002; 41 J Foote (BFnature13764_CR20) 1995; 92 J Sui (BFnature13764_CR1) 2009; 16 I Dogan (BFnature13764_CR24) 2009; 10 H-X Liao (BFnature13764_CR12) 2013; 496 TR Poulsen (BFnature13764_CR21) 2011; 187 T Tiller (BFnature13764_CR32) 2008; 329 J Jacob (BFnature13764_CR10) 1991; 354 8099917 - J Clin Invest. 1993 Jun;91(6):2358-67 21310965 - Science. 2011 Mar 4;331(6021):1203-7 23175789 - Proc Natl Acad Sci U S A. 2013 Jan 2;110(1):264-9 1956400 - Nature. 1991 Dec 5;354(6352):389-92 11961170 - Rheumatology (Oxford). 2002 Apr;41(4):401-10 17996249 - J Immunol Methods. 2008 Jan 1;329(1-2):112-24 19855380 - Nat Immunol. 2009 Dec;10(12):1292-9 19453415 - Influenza Other Respir Viruses. 2007 May;1(3):105-12 24788925 - PLoS Pathog. 2014 May 01;10(5):e1004103 23576673 - Clin Vaccine Immunol. 2013 Jun;20(6):867-76 22224772 - Annu Rev Immunol. 2012;30:429-57 19251591 - Science. 2009 Apr 10;324(5924):246-51 22932267 - Nature. 2012 Sep 27;489(7417):566-70 12620793 - Virology. 2003 Feb 1;306(1):18-24 23969737 - Nat Rev Immunol. 2013 Sep;13(9):693-701 21220454 - J Exp Med. 2011 Jan 17;208(1):181-93 15247913 - Nat Med. 2004 Aug;10(8):871-5 23955151 - Nature. 2013 Sep 19;501(7467):439-43 23921607 - AIDS. 2013 Sep 24;27(15):2335-44 23540694 - Cell. 2013 Mar 28;153(1):126-38 23552890 - Nature. 2013 Apr 25;496(7446):469-76 18614234 - Mol Immunol. 2008 Aug;45(14):3832-9 21798894 - Science. 2011 Aug 12;333(6044):850-6 19234466 - Nat Struct Mol Biol. 2009 Mar;16(3):265-73 22878502 - Science. 2012 Sep 14;337(6100):1343-8 21930965 - J Immunol. 2011 Oct 15;187(8):4229-35 20389023 - J Clin Invest. 2010 May;120(5):1663-73 23671333 - Nucleic Acids Res. 2013 Jul;41(Web Server issue):W34-40 24021876 - Int Immunol. 2013 Dec;25(12):683-95 23440204 - Proc Natl Acad Sci U S A. 2013 Mar 12;110(11):4261-6 21829618 - PLoS One. 2011;6(8):e22365 8621797 - J Clin Invest. 1996 May 1;97(9):2074-80 20439314 - Nucleic Acids Res. 2010 Jul;38(Web Server issue):W695-9 19079604 - PLoS One. 2008;3(12):e3942 6203114 - Proc Natl Acad Sci U S A. 1984 May;81(10):3180-4 18503082 - Nucleic Acids Res. 2008 Jul 1;36(Web Server issue):W503-8 9655489 - Immunity. 1998 Jun;8(6):751-9 7877964 - Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1254-6 19887135 - Vaccine. 2010 Jan 8;28(3):790-7 |
References_xml | – volume: 324 start-page: 246 year: 2009 end-page: 251 ident: CR2 article-title: Antibody recognition of a highly conserved influenza virus epitope publication-title: Science doi: 10.1126/science.1171491 – volume: 8 start-page: 751 year: 1998 end-page: 759 ident: CR19 article-title: Affinity dependence of the B cell response to antigen: a threshold, a ceiling, and the importance of off-rate publication-title: Immunity doi: 10.1016/S1074-7613(00)80580-4 – volume: 110 start-page: 264 year: 2013 end-page: 269 ident: CR18 article-title: Preconfiguration of the antigen-binding site during affinity maturation of a broadly neutralizing influenza virus antibody publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1218256109 – volume: 10 start-page: e1004103 year: 2014 ident: CR16 article-title: Molecular signatures of hemagglutinin stem-directed heterosubtypic human neutralizing antibodies against influenza A viruses publication-title: PLoS Pathog. doi: 10.1371/journal.ppat.1004103 – volume: 306 start-page: 18 year: 2003 end-page: 24 ident: CR28 article-title: Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (FluMist) derived from cold-adapted A/Ann Arbor/6/60 publication-title: Virology doi: 10.1016/S0042-6822(02)00035-1 – volume: 25 start-page: 683 year: 2013 end-page: 695 ident: CR26 article-title: Both mutated and unmutated memory B cells accumulate mutations in the course of the secondary response and develop a new antibody repertoire optimally adapted to the secondary stimulus publication-title: Int. Immunol. doi: 10.1093/intimm/dxt030 – volume: 92 start-page: 1254 year: 1995 end-page: 1256 ident: CR20 article-title: Kinetic and affinity limits on antibodies produced during immune responses publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.92.5.1254 – volume: 329 start-page: 112 year: 2008 end-page: 124 ident: CR32 article-title: Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning publication-title: J. Immunol. Methods doi: 10.1016/j.jim.2007.09.017 – volume: 208 start-page: 181 year: 2011 end-page: 193 ident: CR6 article-title: Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection publication-title: J. Exp. Med. doi: 10.1084/jem.20101352 – volume: 153 start-page: 126 year: 2013 end-page: 138 ident: CR17 article-title: Somatic mutations of the immunoglobulin framework are generally required for broad and potent HIV-1 neutralization publication-title: Cell doi: 10.1016/j.cell.2013.03.018 – volume: 41 start-page: 401 year: 2002 end-page: 410 ident: CR14 article-title: Polymorphism in the immunoglobulin VH gene V1-69 affects susceptibility to rheumatoid arthritis in subjects lacking the HLA-DRB1 shared epitope publication-title: Rheumatology doi: 10.1093/rheumatology/41.4.401 – volume: 10 start-page: 1292 year: 2009 end-page: 1299 ident: CR24 article-title: Multiple layers of B cell memory with different effector functions publication-title: Nature Immunol. doi: 10.1038/ni.1814 – volume: 501 start-page: 439 year: 2013 end-page: 443 ident: CR27 article-title: Cross-neutralization of four paramyxoviruses by a human monoclonal antibody publication-title: Nature doi: 10.1038/nature12442 – volume: 1 start-page: 105 year: 2007 end-page: 112 ident: CR29 article-title: A sensitive retroviral pseudotype assay for influenza H5N1-neutralizing antibodies publication-title: Influenza Other Respi. Viruses doi: 10.1111/j.1750-2659.2007.00016.x – volume: 496 start-page: 469 year: 2013 end-page: 476 ident: CR12 article-title: Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus publication-title: Nature doi: 10.1038/nature12053 – volume: 20 start-page: 867 year: 2013 end-page: 876 ident: CR15 article-title: B cell response and hemagglutinin stalk-reactive antibody production in different age cohorts following 2009 H1N1 influenza virus vaccination publication-title: Clin. Vaccine Immunol. doi: 10.1128/CVI.00735-12 – volume: 41 start-page: W34 year: 2013 end-page: W40 ident: CR36 article-title: IgBLAST: an immunoglobulin variable domain sequence analysis tool publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkt382 – volume: 81 start-page: 3180 year: 1984 end-page: 3184 ident: CR11 article-title: Generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.81.10.3180 – volume: 16 start-page: 265 year: 2009 end-page: 273 ident: CR1 article-title: Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses publication-title: Nature Struct. Mol. Biol. doi: 10.1038/nsmb.1566 – volume: 45 start-page: 3832 year: 2008 end-page: 3839 ident: CR35 article-title: Analysis and improvements to Kabat and structurally correct numbering of antibody variable domains publication-title: Mol. Immunol. doi: 10.1016/j.molimm.2008.05.022 – volume: 187 start-page: 4229 year: 2011 end-page: 4235 ident: CR21 article-title: Limits for antibody affinity maturation and repertoire diversification in hypervaccinated humans publication-title: J. Immunol. doi: 10.4049/jimmunol.1000928 – volume: 6 start-page: e22365 year: 2011 ident: CR38 article-title: High-resolution description of antibody heavy-chain repertoires in humans publication-title: PLoS ONE doi: 10.1371/journal.pone.0022365 – volume: 27 start-page: 2335 year: 2013 end-page: 2344 ident: CR30 article-title: Identification of TRIM22 single nucleotide polymorphisms associated with loss of inhibition of HIV-1 transcription and advanced HIV-1 disease publication-title: AIDS doi: 10.1097/01.aids.0000432474.76873.5f – volume: 13 start-page: 693 year: 2013 end-page: 701 ident: CR22 article-title: Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning publication-title: Nature Rev. Immunol. doi: 10.1038/nri3516 – volume: 354 start-page: 389 year: 1991 end-page: 392 ident: CR10 article-title: Intraclonal generation of antibody mutants in germinal centres publication-title: Nature doi: 10.1038/354389a0 – volume: 110 start-page: 4261 year: 2013 end-page: 4266 ident: CR8 article-title: Somatic hypermutation maintains antibody thermodynamic stability during affinity maturation publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1301810110 – volume: 333 start-page: 850 year: 2011 end-page: 856 ident: CR4 article-title: A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins publication-title: Science doi: 10.1126/science.1205669 – volume: 120 start-page: 1663 year: 2010 end-page: 1673 ident: CR7 article-title: Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine publication-title: J. Clin. Invest. doi: 10.1172/JCI41902 – volume: 489 start-page: 566 year: 2012 end-page: 570 ident: CR9 article-title: Structural and genetic basis for development of broadly neutralizing influenza antibodies publication-title: Nature doi: 10.1038/nature11371 – volume: 3 start-page: e3942 year: 2008 ident: CR5 article-title: Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells publication-title: PLoS ONE doi: 10.1371/journal.pone.0003942 – volume: 28 start-page: 790 year: 2010 end-page: 797 ident: CR33 article-title: A practical influenza neutralization assay to simultaneously quantify hemagglutinin and neuraminidase-inhibiting antibody responses publication-title: Vaccine doi: 10.1016/j.vaccine.2009.10.066 – volume: 36 start-page: W503 year: 2008 end-page: W508 ident: CR37 article-title: IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkn316 – volume: 10 start-page: 871 year: 2004 end-page: 875 ident: CR31 article-title: An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus publication-title: Nature Med. doi: 10.1038/nm1080 – volume: 91 start-page: 2358 year: 1993 end-page: 2367 ident: CR39 article-title: A fetally expressed immunoglobulin VH1 gene belongs to a complex set of alleles publication-title: J. Clin. Invest. doi: 10.1172/JCI116468 – volume: 337 start-page: 1343 year: 2012 end-page: 1348 ident: CR3 article-title: Highly conserved protective epitopes on influenza B viruses publication-title: Science doi: 10.1126/science.1222908 – volume: 30 start-page: 429 year: 2012 end-page: 457 ident: CR23 article-title: Germinal centers publication-title: Annu. Rev. Immunol. doi: 10.1146/annurev-immunol-020711-075032 – volume: 97 start-page: 2074 year: 1996 end-page: 2080 ident: CR13 article-title: Expression of the immunoglobulin VH gene 51p1 is proportional to its germline gene copy number publication-title: J. Clin. Invest. doi: 10.1172/JCI118644 – volume: 331 start-page: 1203 year: 2011 end-page: 1207 ident: CR25 article-title: Different B cell populations mediate early and late memory during an endogenous immune response publication-title: Science doi: 10.1126/science.1201730 – volume: 38 start-page: W695 year: 2010 end-page: W699 ident: CR34 article-title: A new bioinformatics analysis tools framework at EMBL-EBI publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkq313 – volume: 496 start-page: 469 year: 2013 ident: BFnature13764_CR12 publication-title: Nature doi: 10.1038/nature12053 – volume: 187 start-page: 4229 year: 2011 ident: BFnature13764_CR21 publication-title: J. Immunol. doi: 10.4049/jimmunol.1000928 – volume: 354 start-page: 389 year: 1991 ident: BFnature13764_CR10 publication-title: Nature doi: 10.1038/354389a0 – volume: 10 start-page: 1292 year: 2009 ident: BFnature13764_CR24 publication-title: Nature Immunol. doi: 10.1038/ni.1814 – volume: 38 start-page: W695 year: 2010 ident: BFnature13764_CR34 publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkq313 – volume: 1 start-page: 105 year: 2007 ident: BFnature13764_CR29 publication-title: Influenza Other Respi. Viruses doi: 10.1111/j.1750-2659.2007.00016.x – volume: 8 start-page: 751 year: 1998 ident: BFnature13764_CR19 publication-title: Immunity doi: 10.1016/S1074-7613(00)80580-4 – volume: 25 start-page: 683 year: 2013 ident: BFnature13764_CR26 publication-title: Int. Immunol. doi: 10.1093/intimm/dxt030 – volume: 337 start-page: 1343 year: 2012 ident: BFnature13764_CR3 publication-title: Science doi: 10.1126/science.1222908 – volume: 28 start-page: 790 year: 2010 ident: BFnature13764_CR33 publication-title: Vaccine doi: 10.1016/j.vaccine.2009.10.066 – volume: 306 start-page: 18 year: 2003 ident: BFnature13764_CR28 publication-title: Virology doi: 10.1016/S0042-6822(02)00035-1 – volume: 41 start-page: W34 year: 2013 ident: BFnature13764_CR36 publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkt382 – volume: 120 start-page: 1663 year: 2010 ident: BFnature13764_CR7 publication-title: J. Clin. Invest. doi: 10.1172/JCI41902 – volume: 324 start-page: 246 year: 2009 ident: BFnature13764_CR2 publication-title: Science doi: 10.1126/science.1171491 – volume: 333 start-page: 850 year: 2011 ident: BFnature13764_CR4 publication-title: Science doi: 10.1126/science.1205669 – volume: 20 start-page: 867 year: 2013 ident: BFnature13764_CR15 publication-title: Clin. Vaccine Immunol. doi: 10.1128/CVI.00735-12 – volume: 10 start-page: e1004103 year: 2014 ident: BFnature13764_CR16 publication-title: PLoS Pathog. doi: 10.1371/journal.ppat.1004103 – volume: 92 start-page: 1254 year: 1995 ident: BFnature13764_CR20 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.92.5.1254 – volume: 329 start-page: 112 year: 2008 ident: BFnature13764_CR32 publication-title: J. Immunol. Methods doi: 10.1016/j.jim.2007.09.017 – volume: 13 start-page: 693 year: 2013 ident: BFnature13764_CR22 publication-title: Nature Rev. Immunol. doi: 10.1038/nri3516 – volume: 110 start-page: 4261 year: 2013 ident: BFnature13764_CR8 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1301810110 – volume: 97 start-page: 2074 year: 1996 ident: BFnature13764_CR13 publication-title: J. Clin. Invest. doi: 10.1172/JCI118644 – volume: 6 start-page: e22365 year: 2011 ident: BFnature13764_CR38 publication-title: PLoS ONE doi: 10.1371/journal.pone.0022365 – volume: 153 start-page: 126 year: 2013 ident: BFnature13764_CR17 publication-title: Cell doi: 10.1016/j.cell.2013.03.018 – volume: 501 start-page: 439 year: 2013 ident: BFnature13764_CR27 publication-title: Nature doi: 10.1038/nature12442 – volume: 3 start-page: e3942 year: 2008 ident: BFnature13764_CR5 publication-title: PLoS ONE doi: 10.1371/journal.pone.0003942 – volume: 208 start-page: 181 year: 2011 ident: BFnature13764_CR6 publication-title: J. Exp. Med. doi: 10.1084/jem.20101352 – volume: 91 start-page: 2358 year: 1993 ident: BFnature13764_CR39 publication-title: J. Clin. Invest. doi: 10.1172/JCI116468 – volume: 110 start-page: 264 year: 2013 ident: BFnature13764_CR18 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1218256109 – volume: 81 start-page: 3180 year: 1984 ident: BFnature13764_CR11 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.81.10.3180 – volume: 41 start-page: 401 year: 2002 ident: BFnature13764_CR14 publication-title: Rheumatology doi: 10.1093/rheumatology/41.4.401 – volume: 36 start-page: W503 year: 2008 ident: BFnature13764_CR37 publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkn316 – volume: 331 start-page: 1203 year: 2011 ident: BFnature13764_CR25 publication-title: Science doi: 10.1126/science.1201730 – volume: 10 start-page: 871 year: 2004 ident: BFnature13764_CR31 publication-title: Nature Med. doi: 10.1038/nm1080 – volume: 27 start-page: 2335 year: 2013 ident: BFnature13764_CR30 publication-title: AIDS doi: 10.1097/01.aids.0000432474.76873.5f – volume: 45 start-page: 3832 year: 2008 ident: BFnature13764_CR35 publication-title: Mol. Immunol. doi: 10.1016/j.molimm.2008.05.022 – volume: 16 start-page: 265 year: 2009 ident: BFnature13764_CR1 publication-title: Nature Struct. Mol. Biol. doi: 10.1038/nsmb.1566 – volume: 30 start-page: 429 year: 2012 ident: BFnature13764_CR23 publication-title: Annu. Rev. Immunol. doi: 10.1146/annurev-immunol-020711-075032 – volume: 489 start-page: 566 year: 2012 ident: BFnature13764_CR9 publication-title: Nature doi: 10.1038/nature11371 – reference: 11961170 - Rheumatology (Oxford). 2002 Apr;41(4):401-10 – reference: 23440204 - Proc Natl Acad Sci U S A. 2013 Mar 12;110(11):4261-6 – reference: 23175789 - Proc Natl Acad Sci U S A. 2013 Jan 2;110(1):264-9 – reference: 8621797 - J Clin Invest. 1996 May 1;97(9):2074-80 – reference: 23671333 - Nucleic Acids Res. 2013 Jul;41(Web Server issue):W34-40 – reference: 23552890 - Nature. 2013 Apr 25;496(7446):469-76 – reference: 23576673 - Clin Vaccine Immunol. 2013 Jun;20(6):867-76 – reference: 21930965 - J Immunol. 2011 Oct 15;187(8):4229-35 – reference: 21220454 - J Exp Med. 2011 Jan 17;208(1):181-93 – reference: 23969737 - Nat Rev Immunol. 2013 Sep;13(9):693-701 – reference: 21798894 - Science. 2011 Aug 12;333(6044):850-6 – reference: 6203114 - Proc Natl Acad Sci U S A. 1984 May;81(10):3180-4 – reference: 19855380 - Nat Immunol. 2009 Dec;10(12):1292-9 – reference: 21829618 - PLoS One. 2011;6(8):e22365 – reference: 19453415 - Influenza Other Respir Viruses. 2007 May;1(3):105-12 – reference: 20439314 - Nucleic Acids Res. 2010 Jul;38(Web Server issue):W695-9 – reference: 18503082 - Nucleic Acids Res. 2008 Jul 1;36(Web Server issue):W503-8 – reference: 23955151 - Nature. 2013 Sep 19;501(7467):439-43 – reference: 24021876 - Int Immunol. 2013 Dec;25(12):683-95 – reference: 21310965 - Science. 2011 Mar 4;331(6021):1203-7 – reference: 19887135 - Vaccine. 2010 Jan 8;28(3):790-7 – reference: 22878502 - Science. 2012 Sep 14;337(6100):1343-8 – reference: 9655489 - Immunity. 1998 Jun;8(6):751-9 – reference: 17996249 - J Immunol Methods. 2008 Jan 1;329(1-2):112-24 – reference: 18614234 - Mol Immunol. 2008 Aug;45(14):3832-9 – reference: 19234466 - Nat Struct Mol Biol. 2009 Mar;16(3):265-73 – reference: 12620793 - Virology. 2003 Feb 1;306(1):18-24 – reference: 22932267 - Nature. 2012 Sep 27;489(7417):566-70 – reference: 19079604 - PLoS One. 2008;3(12):e3942 – reference: 19251591 - Science. 2009 Apr 10;324(5924):246-51 – reference: 23540694 - Cell. 2013 Mar 28;153(1):126-38 – reference: 7877964 - Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1254-6 – reference: 23921607 - AIDS. 2013 Sep 24;27(15):2335-44 – reference: 8099917 - J Clin Invest. 1993 Jun;91(6):2358-67 – reference: 1956400 - Nature. 1991 Dec 5;354(6352):389-92 – reference: 20389023 - J Clin Invest. 2010 May;120(5):1663-73 – reference: 24788925 - PLoS Pathog. 2014 May 01;10(5):e1004103 – reference: 22224772 - Annu Rev Immunol. 2012;30:429-57 – reference: 15247913 - Nat Med. 2004 Aug;10(8):871-5 |
SSID | ssj0005174 |
Score | 2.5766258 |
Snippet | The main pathway of somatic mutations leading to the generation of high affinity broadly neutralizing antibodies against the influenza haemagglutinin stem is... The neutralizing antibody response to influenza virus is dominated by antibodies that bind to the globular head of haemagglutinin, which undergoes a continuous... |
SourceID | proquest gale pubmed crossref springer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 418 |
SubjectTerms | 13/56 631/250/2152/2040 Adult Amino Acid Sequence Antibodies Antibodies, Neutralizing - genetics Antigens Cells, Cultured Cloning Complementarity Determining Regions - chemistry Complementarity Determining Regions - genetics Female Gene mutations Genetic aspects Health aspects Hemagglutinin Glycoproteins, Influenza Virus - immunology Humanities and Social Sciences Humans Immunoglobulin Heavy Chains - genetics Influenza Influenza research Influenza, Human - immunology Influenza, Human - virology letter Male Middle Aged Models, Molecular multidisciplinary Mutation Mutation - genetics Orthomyxoviridae - immunology Orthomyxoviridae - metabolism Polymorphism, Genetic Protein binding Protein Binding - genetics Protein Structure, Tertiary Rodents Science Viral antibodies Viruses Young Adult |
Title | Rapid development of broadly influenza neutralizing antibodies through redundant mutations |
URI | https://link.springer.com/article/10.1038/nature13764 https://www.ncbi.nlm.nih.gov/pubmed/25296253 https://www.proquest.com/docview/1640677691 https://www.proquest.com/docview/1639498203 |
Volume | 516 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwED-xTUi8IDa-wkZl0PiUotmJ7TpPaEwrg4cJFSZVvES2Y0-VRtI17QP767ETt0vKxEte7mJHZ_t88f38O4BDLIUhwohYZtjElCkdqzTTMbFcY-XiA6YblO85P7ug3yZsEg7c6gCrXPnExlEXlfZn5EcurPdkZzwjn2bXsa8a5bOroYTGFuwQ54M9d7446UA8NliYw_08nIqjljaTuOVFezvSpl_ubEwbmdJmAxo9gochckTH7VDvwj1T7sH9BsGp6z3YDau0Ru8DlfSHx_BrLGfTAhW3yCBUWaTmlSyu_qBpW6DkRqLSLJsTjxvXM3K2nqrKowtRqOKD5sZfNnMC9HvZ5u7rJ3AxOv15chaHagqxZoIvYkmIsaxQ1v2hsYTywhJqCpV4oKfQqbZa8EwryQWzWie8wFi6vwmaGuNMaWX6FLbLqjTPARVCuMAo8SnZIcWKKxfjYINTjTW2LGERfFxZNNeBatxXvLjKm5R3KvKO-SM4XCvPWoaNu9Ve-6HJPWdF6UExl3JZ1_nXH-P8mPIm_UlJBO-Ckq1ch1qGOwbusz3NVU9zv6epZ9PrvCN925NetuN2VzMHPUW3NnVfvJpIefANdX47kyN4tRb7Nz3erTTV0uukGc1cdJZG8KydgGvjJD5VnjAnebOakZ3G_7Xci_9_xD48cEFgQ15JxAFsL-ZL89IFWgs1gK3hZDho1pR_jr4MYOfz6fn38V_86ynf |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LT9wwEB5Rqqq9VIW-UmjrVtAHUoQTO8E5VBWiRbuFcqAgoV6C7ThoJZosm40q-FH9jR3nsSRb1BvnmdjReDyeZD5_A7BGpTCeMMKVETUuD5R2FYu066Whpgrzg0BXKN-DcHDMv50EJwvwp70LY2GVbUysAnWSa_uPfBPTekt2Fkbe5_GFa7tG2epq20Kjdos9c_kbP9mKT8MvuL7rvr_79Whn4DZdBVwdiHDqSs8zaZCoFL9UAp-HSepxkyjfAh6FZjrVIoy0kqEIUq39MKFUYlbNmTEYPlLJcNw7cJcztmW5-sVOB1Iyx_rc3AekTGzWNJ0ebmfeOwHnz4HOQThXma0OvN1H8LDJVMl27VpLsGCyZbhXIUZ1sQxLTVQoyIeGuvrjY_h5KMejhCTXSCSSp0RNcpmcX5JR3RDlSpLMlNUfliucmeDajlRu0Yyk6RpEJsZebkMB-VXWWIHiCRzfip2fwmKWZ-Y5kEQITMR8WwLe4lSFCnMqaijTVNM08AMHNlqLxrqhNrcdNs7jqsTORNwxvwNrM-Vxzehxs9pbuzSx5cjILAjnTJZFEQ9_HMbbPKzKrdxz4H2jlOY4oZbNnQZ8bUur1dNc6Wnq8egi7kjf9aRn9brdNMxqTxFjge6LW0eKm1hUxNc7x4E3M7F90uLrMpOXVodFPMJskDnwrHbAmXF8W5r3A5Sstx7ZGfxfy734_0u8hvuDo-_78f7wYG8FHmACWhFnemIVFqeT0rzEJG-qXlU7i8DpbW_lvxF4ZCQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NIRAviI2vsAEGbXxJUZ3POg8ITYxqZWhCg0kVL8F27KnSSLqmEdr-NP46zonTNmXibc93saPzfSX38x3ADuVMeUwxlydUuWEkpCuCRLqejiUVmB9Eskb5HsUHJ-HnUTRagz_tXRgDq2x9Yu2os0Kaf-Q9TOtNs7M48XrawiK-7g8-TM5dM0HKVFrbcRqNihyqi9_4-Va-H-7jWe_6_uDT948Hrp0w4MqIxTOXe57SUSY0frVEfhhn2gtVJnwDfmQykFqyOJGCxyzSUvpxRinHDDsMlEJXonmA696Am_0AwybaUn_UX8BLVjpA27uBNGC9pmWnh6YddqLhakxYCoorVdo6-A3uwV2btZK9Rs02YE3lm3CrRo_KchM2rIcoyRvbxvrtffhxzCfjjGQLVBIpNBHTgmdnF2TcDEe55CRXVf235RJ3JnjOY1EYZCOxE4TIVJmLbkggv6oGN1A-gJNrkfNDWM-LXD0GkjGGSZlvysH9kIpYYH5FFQ0klVRHfuTAu1aiqbRtzs20jbO0LrcHLF0SvwM7c-ZJ093jaraX5mhS0y8jN5p3yquyTIffjtO9MK5Lr6HnwGvLpAvcUHJ7vwFf27TY6nBudTjlZHyeLlFfdainzbldtcx2hxH9guySW0VKrV8q04UVOfBiTjZPGqxdrorK8ARJmGBmGDjwqFHAuXB8U6b3I6Tsthq5tPi_knvy_5d4DrfRiNMvw6PDLbiDuWjdQ9Nj27A-m1bqKeZ7M_GsNiwCP6_bkv8CAtBohg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Rapid+development+of+broadly+influenza+neutralizing+antibodies+through+redundant+mutations&rft.jtitle=Nature+%28London%29&rft.au=Pappas%2C+Leontios&rft.au=Foglierini%2C+Mathilde&rft.au=Piccoli%2C+Luca&rft.au=Kallewaard%2C+Nicole+L.&rft.date=2014-12-18&rft.pub=Nature+Publishing+Group+UK&rft.issn=0028-0836&rft.eissn=1476-4687&rft.volume=516&rft.issue=7531&rft.spage=418&rft.epage=422&rft_id=info:doi/10.1038%2Fnature13764&rft.externalDocID=10_1038_nature13764 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0028-0836&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0028-0836&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0028-0836&client=summon |